Journals / Haseki Tıp Bülteni / 2010 / Cilt: 48 - Sayı: 1

Sweet’s syndrome accompanying acute myelomonocytic

AML FAB M4’e Efllik Eden sweet sendromu olgusu

Pages
44–46
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here, we present a case of AML-M4 and Sweet’s syndrome, who responded rapidly to corticosteroid treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Sweet’s syndrome is a skin disease, which can be described as acute febrile neutrophilic dermatosis and can accompany infectious diseases and malignancies.
📊
Key Findings & Data:Sweet’s syndrome is most often seen with myeloblastic leukemia.
💡
Conclusion & Impact:Here, we present a case of AML-M4 and Sweet’s syndrome, who responded rapidly to corticosteroid treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Sweet’s syndrome is a skin disease, which can be described as acute febrile neutrophilic dermatosis and can accompany infectious diseases and malignancies. Sweet’s syndrome is most often seen with myeloblastic leukemia. There is dramatically good response to corticosteroids in this syndrome. Here, we present a case of AML-M4 and Sweet’s syndrome, who responded rapidly to corticosteroid treatment.

Özet

Sweet sendromu akut febril nötrofilik dermatoz olarak tanımlanan bir deri hastalığıdır. infeksiyon hastalıklarına, malig-nitelere eşlik edebilir. En sık akut myeloblastik lösemide görülür. Kortikosteroid tedavisine dramatik olarak iyi yanıt verir. Burada kortikosteroid tedavisine hızla yanıt veren Sweet sendromlu bir AML M4 olgusu sunulmuştur.

🔖

Cite This Article

AKARSU, Ö., ÖZŞENEL, E. B., KURNAZ, S., TUĞRUL, M., AYER, M., COŞGUN, S., ŞAR, F., KAZANCIOĞLU, R., ÖZTÜRK, S. (2010). Sweet’s syndrome accompanying acute myelomonocytic. Haseki Tıp Bülteni, Cilt: 48 - Sayı: 1, 44–46. https://ajindex.com/articles/268048

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Lichtman MA. Acute myelogenous leukemia. In: Williams Hematology, Eds: Beutler E, Lichtman MA, Coller BC, Kipps TJ, New York: McGraw-Hill Co. 1995. p. 272-98
  2. Rowe JM, Liesveld JL. Treatment and prognostic factors in acute myeloid leukemia. Baillier’s Clin Haematol 1996;9:87-105. [Abstract] / [Full Text] 3. Cohen PR, Kurzrock R. Sweet's syndrome and malignancy. Am J Med 1987;82:1220-6
  3. Thompson DF, Montarella KE. Drug-Induced Sweet's Syndrome. Ann Pharmacother 2007;41:802-11. [Abstract] / [PDF] 5. Cohen PR. Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 2007;2:34. [Abstract] / [Full Text] / [PDF] 6. Sweet RD. An acute febrile neutrophilic dermatosis. Br J Dermatol 1964;76:349-56. [Abstract] 7. Hatch ME, Farber SS, Superfon NP, Ligorsky RD, Williams HE. Sweet's syndrome associated with chronic myelogenous leukemia. JAOA 1989;89:363. [Abstract] 8. Heer-Sonderhoff AH, Arning M, Wehmeier A, Südhoff T, Zumdick M. Neutrophilic dermal infiltrates in granulocytopenic patients with acute leukemia. Ann Hematol 1995;71:257-61. [Abstract] / [PDF] 9. Hönigsmann H, Wolff K. Acute febrile neutrophilic dermatosis (Sweet’s syndrome). Dermatology in General Medicine. Ed. Fitzpatrick TB, Eisen AZ, Wolf K, Freedberg IM, Austen. Newyork, Mc Graw Hill Book Co 1993;1152-5
  4. Vance E, Granter S, Skarin A. Sweet’s syndrome. J Clin Oncol 1997;15:860-1. [PDF] 11. Su WP, Liu HN. Diagnostic criteria for Sweet’s syndrome. Cutis 1986;37:167-74. [Abstract] 12. Avivi I, Rosenbaum H, Levy Y, Rowe J. Myelodysplastic syndrome and associated skin lesions: a review of the literature. Leuk Res 1999;23:323-30. [Abstract] / [Full Text] / [PDF] 13. Cohen PR, Kurzrock R. Sweet's syndrome: a review of current treatment options. Am J Clin Dermatol 2002;3:117-31. [Abstract] 14. Braun-Falco O, Plewing G, Wolff HH, Burgdorf WHC. Pustular diseases. Dermatology
  5. Bask›. Berlin: Springer- Verlag, 2000;583-4
  6. Evans AV, Sabroe RA, Liddell K, Russell-Jones R. Lymphocytic infiltrates as a presenting feature of Sweet’s syndrome with myelodysplasia and response to cyclophosphamide. Br J Dermatol 2002;146:1087-90. [Abstract] / [Full Text] / [PDF] 16. Cohen PR, Kurzrock R. Chronic myelogenous leukemia and Sweet syndrome. Am J Hematol 1989;32:134-7. [Abstract] 17. Hönigsmann H, Ohen PR, Wollf K. Acute febrile neutrophilic dermatosis (Sweet’s Syndrome) Dermatology in General Medicine. Ed. Fitzpatrick TB, Freedberg IM, Eisen AZ, Wollf K, Aust